Sodium MRI in Pediatric Brain Tumors
American Journal of Neuroradiology · 2024
DOI: 10.3174/ajnr.a8642 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Neuroradiology, 2024. Verfasst von Aashim Bhatia und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology (A.B., T.P.L.R.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania aashimbhatia@gmail.com. Hauptthemen laut MEDLINE: Brain Neoplasms, Magnetic Resonance Imaging, Sodium. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Defense, American Brain Tumor Association, Society of Pediatric Radiology.
Abstract (Originalsprache)
Direct sodium MRI (23Na-MRI) derives its signal from spin-manipulation of the 23Na nucleus itself and not the more conventional and familiar 1H-MRI. Although present at much lower concentrations in the human body than the 1H nuclei in the water molecule H2O, advances in coil design and pulse sequence development have enabled the feasibility of human in vivo 23Na-MRI. Additionally, 23Na-MRI has the potential to offer nuanced physiologic insights not available to conventional MRI; this feature forms the basis of interest in its development and optimism for its novel clinical utility. 23Na-MRI has the potential to be a useful noninvasive imaging technique to assess biochemical and physiologic cellular changes in tissues, eg, cell integrity and tissue viability. Pathologically, the concentration of total sodium is elevated in tumors relative to normal counterparts due to increased intracellular sodium and/or an increased proportion of extracellular space (reflecting changes in cell morphology and anomalies of homeostasis). Here we review the technological advancements with improved pulse sequences and reconstruction methods that counter the inherent challenges of measuring sodium concentrations in the pediatric brain (in particular, its short-tissue T2 value) and present detailed imaging approaches to quantifying sodium concentrations in the pediatric brain that can be assessed in various CNS pathologies, with the focus on pediatric brain tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Radiology (A.B., T.P.L.R.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania aashimbhatia@gmail.com.
- Division of Oncology (C.K., M.J.F.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
- Division of Neurosurgery (P.J.M.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
- Radiological Sciences Laboratory (F.E.B.), School of Medicine, Stanford, California.
- From the Department of Radiology (A.B., T.P.L.R.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
ORCID-Profile: Aashim Bhatia, Timothy P L Roberts
Förderung
- U.S. Department of Defense
- American Brain Tumor Association
- Society of Pediatric Radiology
Zitieren
APA
Bhatia, A., Kline, C., Madsen, P. J., Fisher, M. J., Boada, F. E., & Roberts, T. P. L. (2024). Sodium MRI in Pediatric Brain Tumors. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8642
Vancouver
Bhatia A, Kline C, Madsen PJ, Fisher MJ, Boada FE, Roberts TPL. Sodium MRI in Pediatric Brain Tumors. American Journal of Neuroradiology. 2024. doi:10.3174/ajnr.a8642
BibTeX
@article{Bhatia2024,
author = {Bhatia, Aashim and Kline, Cassie and Madsen, Peter J and Fisher, Michael J and Boada, Fernando E and Roberts, Timothy P L},
title = {Sodium MRI in Pediatric Brain Tumors},
journal = {American Journal of Neuroradiology},
year = {2024},
doi = {10.3174/ajnr.a8642}
}
EUVIMED